GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Penumbra Inc (MEX:PEN) » Definitions » Other Operating Expense

Penumbra (MEX:PEN) Other Operating Expense : MXN-0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Penumbra Other Operating Expense?

Penumbra's Other Operating Expense for the three months ended in Mar. 2025 was MXN0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was MXN-0 Mil.

Penumbra's quarterly Other Operating Expense declined from Sep. 2024 (MXN0 Mil) to Dec. 2024 (MXN-0 Mil) but then increased from Dec. 2024 (MXN-0 Mil) to Mar. 2025 (MXN0 Mil).

Penumbra's annual Other Operating Expense increased from Dec. 2022 (MXN0 Mil) to Dec. 2023 (MXN0 Mil) but then declined from Dec. 2023 (MXN0 Mil) to Dec. 2024 (MXN-0 Mil).


Penumbra Other Operating Expense Historical Data

The historical data trend for Penumbra's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Penumbra Other Operating Expense Chart

Penumbra Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Penumbra Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Penumbra Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Penumbra Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Penumbra's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Penumbra Business Description

Traded in Other Exchanges
Address
One Penumbra Place, Alameda, CA, USA, 94502
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.